Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial
口服LPCN 1148可改善男性肝硬化患者的肌肉减少症和肝性脑病:一项随机、安慰剂对照的II期试验
期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000001146
Bruno, Benjamin J; Weavil, Joshua C; Ogle, Jonathan; Chidambaram, Nachiappan; Carey, Elizabeth J; Danford, Christopher J; Fricker, Zachary P; Galati, Joseph S; Lee, William M; Mantry, Parvez S; Shetty, Kirti; DelConte, Anthony; Patel, Mahesh V; Lai, Jennifer C; Sanyal, Arun J